Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Amortization of Deferred Charges: 2021-2025

Historic Amortization of Deferred Charges for Core Scientific (CORZ) over the last 4 years, with Sep 2025 value amounting to $1.3 million.

  • Core Scientific's Amortization of Deferred Charges fell 18.42% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 4.51%. This contributed to the annual value of $3.8 million for FY2024, which is 399.47% up from last year.
  • Core Scientific's Amortization of Deferred Charges amounted to $1.3 million in Q3 2025, which was down 19.72% from $1.6 million recorded in Q2 2025.
  • Core Scientific's Amortization of Deferred Charges' 5-year high stood at $6.2 million during Q4 2021, with a 5-year trough of -$190,000 in Q4 2024.
  • Its 3-year average for Amortization of Deferred Charges is $1.1 million, with a median of $1.5 million in 2024.
  • Per our database at Business Quant, Core Scientific's Amortization of Deferred Charges skyrocketed by 1,353.77% in 2022 and then slumped by 125.27% in 2024.
  • Over the past 5 years, Core Scientific's Amortization of Deferred Charges (Quarterly) stood at $6.2 million in 2021, then crashed by 84.59% to $963,000 in 2022, then dropped by 21.91% to $752,000 in 2023, then crashed by 125.27% to -$190,000 in 2024, then dropped by 18.42% to $1.3 million in 2025.
  • Its Amortization of Deferred Charges stands at $1.3 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.7 million for Q1 2025.